Levosimendan
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
C01CX08
CAS registry number (Chemical Abstracts Service)
0141505-33-1
Chemical Formula
C14-H12-N6-O
Molecular Weight
280
Therapeutic Categories
Vasodilator
Cardiac stimulant
Chemical Names
(-)-(R)-4,5-Dihydro-3-{4-[N'-(dicyanmetylen)-hydrazono]phenyl}-4-metylpirdazin-6(1H)-on (IUPAC)
Mesoxalonitrile (-)-(p((R)-1,4,5,6-tetrahydro-4-metyl-6-oxo-3-pyridazinyl)phenyl)hydrazone (WHO)
Mesoxalonitrile [p[(R)-1,4,5,6-tetrahydro-4-metyl-6-oxo-3-pyridazinyl]phenyl]hydrazone (USAN)
Propanedinitrile, [[4-(1,4,5,6-tetrahydro-4-metyl-6-oxo-3-pyridazinyl)phenyl]hydrazono], (R)
Foreign Names
- Levosimendanum (Latin)
- Levosimendan (German)
- Lévosimendan (French)
- Levosimendan (Spanish)
Generic Names
- Levosimendan (OS: USAN)
- Lévosimendan (OS: DCF)
- (-)-OR 1259 (IS: Orion)
Brand Names
- Daxim
Abbott, Venezuela; Abbott Laboratories de Chile, Chile - Levosimendan Richet
Richet, Argentina - Simdax
Abbott, Argentina; Abbott, Latvia; Abbott, Turkey; Abbvie Farmacéuticos, Mexico; Altamedics, Slovenia; Aspen, New Zealand; Haemato Pharm, Austria; Medis Adria, Croatia (Hrvatska); Orion, Austria; Orion, Bulgaria; Orion, Czech Republic; Orion, Estonia; Orion, Spain; Orion, Georgia; Orion, Hungary; Orion, Israel; Orion, Iceland; Orion, Norway; Orion, Oman; Orion, Poland; Orion, Portugal; Orion, Romania; Orion, Serbia; Orion, Slovakia; Orion Corporation - SF, Italy; Orion Pharma, Switzerland; Orion Pharma, Germany; Orion Pharma, Finland; Orion Pharma, Sweden; Orion Pharma, Singapore; Orion Pharma Hellas, Greece; Salus, Slovenia; Sanolabor, Slovenia
← International Drug Name Search
Glossary
| Term | Definition |
|---|---|
| DCF | Dénomination Commune Française |
| IUPAC | International Union of Pure and Applied Chemistry |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
| WHO | World Health Organization |
Click for further information on drug naming conventions and International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
